Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 575-580

  Muiesan, Maria Lorenza ^a   Salvetti, Massimo ^a   Monteduro, Cristina ^a   Rizzoni, Damiano ^a   Zulli, Roberto ^a   Corbellini, Claudia ^a   Brun, Claudia ^a   Agabiti Rosei, Enrico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Antihypertensive therapy; Arteries, brachial; Blood pressure; Hypertension, essential; Vasodilation

Indexed keywords

GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; NIFEDIPINE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

EID: 0032898101     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.575     Document Type: Article

References (42)

1. Luscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton, Fla: CRC Press; 1990.
2. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993; 11:1375-1380.
3. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: 373-376.
4. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
5. Cooke J, Tsao P. Is nitric oxide an endogenous antiatherogenic molecule? Arterioscler Thromb. 1994;14:653-655.
6. Grag UC, Hassid A. Nitric oxide generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1774-1777.
7. Lyons D, Webster J, Benjamin N. The effect of antihypertensive therapy on responsiveness to local intrarterial NG-monomethyl-L-arginine in patients with essential hypertension. J Hypertens. 1994;12:1047-1053.
8. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
9. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
10. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of hypertension. Hypertension. 1993;21: 929-933.
11. Rizzoni D, Porten E, Castellano M, Bettoni G, Muiesan ML, Tiberio G, Giulini SM, Rossi GP, Bernini G, Agabiti-Rosei E. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension. 1998;31(pt 2):335-341.
12. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
13. Laurent S, Lacolley P, Brunel P, Laloux B, Pannier B, Safar M. Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol. 1990;258:H1004-H1011.
14. Rubanyi GM, Romero C, Vanhoutte PM. Flow-induced release of endothelium-dependent relaxing factor. Am J Physiol. 1986;250:1115-1119.
15. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF, Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation. 1995;91: 1314-1319.
16. Lieberman E, Knab S, Creager M. Nitric oxide mediates the vasodilator responses to flow in humans. Circulation. 1994;90(suppl I):I-138. Abstract.
17. Dakak N, Husain S, Mulcahy D, Andrews N, Panza JA, Waclawiw M, Schenke W, Quyyumi AA. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. Hypertension. 1998;32:9-15.
18. Iiyama K, Nagano M, Yo Y, Nagano N, Kamide K, Higaki J, Mikami H, Ogihara T. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J. 1996;132:779-782.
19. Muiesan ML, Salvetti M, Monteduro C, Rizzoni D, Zulli R, Franzoni P, Brun C, Corbellini C, Agabiti-Rosei E. Non invasive assessment of endothelial dysfunction in essential hypertension. Eur Heart J. 1998; 18:474. Abstract.
20. Celermajer DS. Endothelial dysfunction; Does it matter? Is it reversible? J Am Coll Cardiol. 1997;30:325-333.
21. Anderson TJ, Uehata A, Gerhard MD, Meredith JT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235-1241.
22. Clarkson TB, Adams MR, Powe AJ, Donald AE, McCrodie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 1996;97:1989-1994.
23. Vogel RA, Corretti MC, Platnik GD. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle aged men. Am J Cardiol. 1996;77:37-40.
24. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Young AC, Creager MA. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-941.
25. Levine GN, Frei B, Kouloukis SN, Gerhard MO, Keaney JFJ, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996;93:1107-1113.
26. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation. 1996;93: 210-214.
27. Luscher TF, Vanhoutte PM, Raij L. Antihypertensive treatment normalizes decreased endothelium-dependent relaxation in rats with salt-induced hypertension. Hypertension. 1987;9:193-197.
28. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990;16:532-540.
29. Rodrigo E, Maeso R, Munoz-Garcia R, Navarro-Cid J, Ruilope LM, Cachofeiro V, Lahera V. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril. J Hypertens. 1997;15:613-618.
30. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21: 1145-1151.
31. Creager MA, Roddy MA. Effects of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994;24:499-505.
32. Schiffrin EL, Deng L-Y. Comparison of the effects of angiotensin I-converting enzyme inhibition and β-blockade for 2-years on function of small arteries from hypertensive patients. Hypertension. 1995;25(pt 2):699-703.
33. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli R, Bettoni G, Salvetti M, Monteduro C, Agabiti-Rosei E. Effects of long-term therapy with lisinopril on resistance arteries of hypertensive patients with left ventricular hypertrophy. J Hypertens. 1997;15:197-204.
34. Taddei S, Virdis A, Ghiadoni L, Uleri S, Magagna A, Salvetti S. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension. 1997;30:1606-1612.
35. Schiffrin EL, Deng L-Y. Structure and function of resistance arteries of hypertensive patients treated with a β-blocker or a calcium channel antagonists. J Hypertens. 1996;14:1247-1255.
36. Muiesan ML, Pasini GF, Salvetti M, Calebich S, Zulli R, Castellano M, Rizzoni D, Bettoni G, Porteri E, Agabiti-Rosei E. Cardiac and vascular structural changes: prevalence and relation to ambulatory blood pressure in a middle aged general population in Northern Italy: the Vobarno Study. Hypertension. 1996;27:1046-1053.
37. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, Deanfield JE. Non-invasive measurement of endothelium-dependent arterial responses in man: accuracy and reproducibility. Br Heart J. 1995;74:247-253.
38. Laurent S, Lacolley P, Brunel P, Laloux B, Pannier B, Safar M. Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol. 1990;258:H1004-H1011.
39. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468-1474.
40. Heitzer T, Yla-Herttauala S, Luoma J, Kurz S, Munzel T, Just H, Olschewski M, Drexler H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation. 1996;93:1346-1353.
41. Casino PR, Kilcoyene CM, Cannon RO III, Quyyumi AA, Panza J. Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol. 1995;74:40-44.
42. Zanchetti A, Bond G, Hennig M, Neiss A, Mancia G, Dal Palu C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R, on behalf of the ELSA Investigators. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998;16:949-961.